Objectives This study aims to understand the natural history of early-stage hypertrophic cardiomyopathy (HCM) patients and ...
Background Diabetes mellitus (DM) is associated with an increased risk of cardiovascular disease, but its relationship with ...
Background Angiographic parameters can facilitate the risk stratification of coronary lesions but remain insufficient in the prediction of future myocardial infarction (MI). AIMS We compared the ...
Two phase III, double-blind studies randomised hypertriglyceridemic patients to marine omega-3s (icosapent ethyl trade name Vascepa 4 g/day, Vascepa 2 g/day or placebo).12 These included patients on ...
Background It has been reported that recovery of left ventricular ejection fraction (LVEF) is associated with better prognosis in heart failure (HF) patients with reduced EF (rEF). However, change of ...
Background A large electronic health record study presented at the American Heart Association Scientific Sessions 2025 reported a heart failure safety signal associated with long-term melatonin use ...
Background The specific relationship between different blood pressure measures and the risk of aortic aneurysms (AA) remains unclear. Elucidating these associations would be conducive to identifying ...
Objective To undertake a systematic review and meta-analysis examining the impact of polypharmacy on health outcomes in atrial fibrillation (AF). Data sources PubMed and Embase databases were searched ...
Objective Cardiovascular multimorbidity (CVM) is the co-occurrence of multiple cardiovascular disease subtypes (CVDs) in one person. Because common patterns and incidence of CVM are not well-described ...
Background Transcatheter aortic valve implantation (TAVI) is a well-established treatment for severe aortic stenosis but not recommended for patients with a life-expectancy below 1 year. Nevertheless, ...
Objective When advising patients about possible initiation of primary prevention treatment, clinicians currently do not have information on expected impact on lifespan, nor how much this increment ...